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Germany has profited from the internationalization of research and development 
(R&D) in multinational companies. While the international R&D balance sheet was 
balanced until 2001, foreign companies now invest more in R&D in Germany than 
German companies abroad. The share of R&D expenditures of German multinationals 
abroad is declining, whereas their global expenditures are increasing. This means the 
internationalization of R&D activities in Germany has slowed down.
Strategic restructuring of multinational companies is the decisive factor for interna-
tionalizing R&D, not relocation. Against this background, current plans for tax relief 
for R&D will probably not lead to significant backshoring of foreign R&D activities 
to Germany.
In industrialized countries, multinational corporations account for most of the expen-
ditures for research and development (R&D).1 They are also increasing their R&D 
activities abroad. Continuing internationalization can be observed internally through 
rising shares of R&D expenditures of foreign companies in total R&D expenditures 
in the economy. Stronger growth of R&D activities of multinational corporations 
abroad than in their home country is proof for external internationalization. 
For globally active companies it is necessary to take on impulse for innovation from 
the most important markets and leading research institutes worldwide. By doing their 
own R&D in the target market, companies adapt their products and technologies to 
the customers’ needs and the conditions of local production. Additionally, supply-
side motives gain in importance. This includes knowledge acquisition through 
cooperation with universities and research institutes as well as recruiting qualified 
engineers and scientists.2 In certain fields, like for example red or green biotech-
nology, another motivation is the possibility to do research without regulation in 
a number of countries.
1  In 2007, 80 percent of R&D expenditures of companies in Germany came from multinational corporations with 
German and foreign majority ownership which also carry out R&D abroad.
2  See OECD: The Internationalisation of Business R&D, Evidence, Impacts and Implications. Paris 2008; Thursby, 
J.G., Thursby, M.C.: Here or There? A Survey of Factors in Multinational R&D Location: Report to the Government/





An analysis of the development of multinational 
corporations’ R&D expenditures in Germany and 
abroad gives us an idea whether a research or in-
novation location is internationally attractive with 
regard to framework conditions for implementing 
new products and technologies, qualified personnel 
and efficient scientific and educational institutes as 
well as local R&D costs.
Internationalization of R&D also plays a role in 
the current discussion on the introduction of tax 
incentives for R&D activities.3 Proponents expect 
German companies to relocate their foreign R&D 
activities back to Germany because of this tax relief. 
Furthermore, future relocation of domestic R&D 
activities to other countries could be prevented.4
DIW Berlin has analyzed R&D internationalization 
in Germany and the USA. The analysis is based 
on sector-specific data on R&D expenditures of 
German companies abroad and foreign companies in 
Germany from 1995 till 2007.5 Internationalization 
3  Germany is (together with Switzerland and Sweden) one of the OECD 
countries without tax relief for R&D activities. However, the introduction 
of such a scheme is part of the current government’s coalition agree-
ment.
4  See Spengel, C. et al.: Steuerliche Förderung von Forschung und Ent-
wicklung (FuE) in Deutschland. Berlin, Heidelberg 2009.
5  Multinational corporations are classified according to the country where 
they are managed. Normally this is also the country of majority ownership. 
See Belitz, H.: Forschung und Entwicklung in multinationalen Unternehmen. 
Studien zum deutschen Innovationssystem Nr. 6-2010, Expertenkommission 
für Forschung und Innovation (Hrsg.) Berlin, February 2010.
of R&D activities of multinational corporations is 
compared with the development in the USA, the 
only country having long-term data in this field.6
R&D expenditures of German 
companies abroad declining
Global R&D expenditures of German multinational 
corporations have only increased by 300 million 
to EUR 38.6bn between 2005 and 2007. This was 
almost completely achieved in Germany. Abroad, 
R&D expenditures even decreased by EUR 2 bil-
lion (nearly 18 percent) to EUR 9.5 billion (see 
Figure 1).
The average proportion of research abroad of 
German companies was about one quarter (2005: 
30 percent). 
The significant decrease of R&D expenditures 
abroad is mainly due to automotive industry and 
the field of computer industry, electrical engineering 
and precision engineering (see Figure 2). These and 
the pharmaceutical industry are the main fields of 
activity of German companies’ foreign R&D (Table 
1). German automobile manufacturers only carried 
out 16 percent of their R&D activities abroad in 
2007, compared to 26 percent two years before. In 
the field of computer industry, electrical engineer-
ing and precision engineering this percentage fell 
from 32 percent  to 20 percent. In both sectors this 
development was determined by demergers and the 
restructuring of large enterprises. One example is 
Daimler’s separation from its US daughter Chrysler, 
which significantly reduced their R&D expenditures 
abroad.7 R&D expenditures abroad of all German 
automobile manufacturers went down by EUR 1.8 
billion between 2005 and 2007. In the computer 
industry, electrical engineering and precision engi-
neering, German R&D expenditures abroad went 
down by EUR 1.1 billion during that time. Siemens 
alone cut its number of employees in R&D working 
abroad by one quarter between 2006 and 2007 (6,900 
employees).8 At the same time, the total number of 
6  Data  for  Germany  have  been  collected  by  Wissenschaftsstatistik 
GmbH  for  Stifterverband  für  die  Deutsche  Wissenschaft  (SV-Wissen-
schaftsstatistik) since the mid-1990s, using their standard biannual eval-
uation of R&D expenditures for special analysis. See also: FuE-Aktivitäten 
deutscher Unternehmen im internationalen Umfeld 2007. In: facts, Zah-
len und Fakten aus der Wissenschaftsstatistik GmbH im Stifterverband,   
Essen, November 2009. In the USA such data have been collected for a 
long time by the Department of Commerce. See U.S. Department of Com-
merce. U.S. Affiliates of Foreign Companies and U.S. Direct Investment 
Abroad.
7  The difference in global R&D expenditures in the according annual 
statements of DaimlerChrysler and Daimler for 2006 is around EUR 1.6 
billion.
8  This has probably caused a decline of R&D expenditures of EUR 600 
to 700 million. Since also domestic R&D staff was reduced in this restruc-
turing process (9,500 employees), the percentage of R&D staff working 
Figure 1 
R&D Expenditures of German and 
Foreign Companies 













1995 1997 1999 2001 2003 2005 2007
Foreign companies in Germany
German companies abroad
German parent companies (right scale)
Sources: SV-Wissenschaftsstatistik, calculations by DIW Berlin. 
    DIW Berlin 2010
German companies are increasing their domestic R&D 
expenditures but do less research abroad.German Companies Do Less Research Abroad
135 DIW Berlin Weekly Report No. 18/2010
employees outside of Germany went down by 13 
percent. Major reasons for the decrease in foreign 
R&D activities by Siemens probably include the 
outsourcing of parts of its communication business 
in a joint venture with Nokia, outsourcing of compu-
ter services in a joint venture with Fujitsu, and sale 
of most of its industrial logistics business.9
These examples show that restructuring processes 
of single large-scale enterprises greatly influence 
internationalization of a country’s business research. 
In most cases, research units stay at their respective 
location. Only in their integration into the new, often 
international R&D structure of the acquiring com-
pany a strategic reorientation and change in R&D 
capacity are made possible.
For German chemical and pharmaceutical compa-
nies, the percentage of foreign R&D expenditures of 
global R&D expenditures was 44 percent in 2007. 
This is roughly the same level of internationali-
zation as in 2001. In the pharmaceutical industry 
foreign R&D expenditures of German companies 
have been stagnating since 2005; however, domestic 
R&D expenditures decreased by 50 percent. This 
has led to a proportion of nearly 70 percent of R&D 
expenditures abroad (2005: 52 percent).
R&D share of foreign companies in 
Germany stays at 25 percent
In Germany, foreign subsidiary companies spent 
around EUR 13.4 billion on R&D in 2007 (2005: 
EUR 12.6 billion) and employed 81,100 persons in 
R&D (2005: 76,600). This means that one quarter 
of R&D expenditure in Germany has come from 
foreign companies since 2001.
Foreign companies have similar technological and 
sector preferences in R&D like their domestic com-
petitors. However, they have a stronger focus on 
pharmaceutical and chemical research as well as 
the aerospace industry (Table 2).
In Germany, about half of researchers work in the 
fields of computer industry, electrical engineering, 
precision engineering and automotive engineer-
ing—this applies to foreign companies as well as 
to domestic ones. The sector with the highest per-
centage of R&D staff in foreign companies (three 
quarters) is vehicle construction (aircraft, spacecraft, 
shipbuilding and railway construction), followed 
by the pharmaceutical industry with a percentage 
of around 50 percent.
abroad rose from 57 to 64 %.
9  See Siemens’ annual reports of 2006 and 2007.
Figure 2 
R&D Expenditures of German and 
Foreign Companies by Selected 
Sectors
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(Table 3). Importance of a country of origin is meas-
ured by its share of R&D staff of foreign companies 
in Germany. Since there was no information on the 
regional distribution of R&D employees of German 
companies abroad, the importance of a target country 
is measured by its percentage in patent applications 
by German companies at the European Patent Office 
with place of invention in the respective country.10 
10 See Belitz, H., Schmidt-Ehmcke, J., Zloscysti, P.: Auslandsforschung 
deutscher Unternehmen—kaum Belege für Abwanderung. Wochenbe-
richt no. 46/2008, DIW Berlin
If we compare the percentage of R&D employees of 
total staff numbers, there is no difference between 
domestic and foreign companies. Their research 
focus and R&D intensity are similar.
Strong links to the USA, Switzerland 
and France
Cross-border  R&D  activities  of  companies  in 
Germany have similar home and target countries 
Table 1
R&D Expenditures of Groups of Companies in Germany and the USA in 2007
In percent
Companies abroad
Foreign companies in respective 
country
Parent company in home country 
(with R&D abroad)
Germany  USA Germany  USA Germany  USA
Automobile industry 31.3 27.01 19 9.92 54.5 7.8
Pharmaceutical industry 22.3 20.3 15.7 37.3 3.2 20.6
Computer industry, electrical 
engineering, precision engineering3
12.3 15.6 20.2 9.7 15.7 19.9
Total 65.9 62.9 54.9 56.9 73.2 48.3
1   2005.
2   2006.
3   For the USA, only figures for the computer and electronic industry are given according to national sector classification.
Sources: SV-Wissenschaftsstatistik, US Department of Commerce, calculations by DIW Berlin. DIW Berlin 2010
R&D internationalization in Germany and the USA is focused on three sectors: Automobile industry, pharmaceutical 
industry and computer industry/electrical engineering.
Table 2




foreign companies in 
percent
Sectoral structure of R&D intensity 1 of
German foreign  German foreign 
companies in percent companies in percent companies in percent
Total 316 599 235 463 81 136 25.6 100 100 7.7 8.5
Thereof:
Professional services 32 649 28 396 4 253 13.0 12.1 5.2 15.7 12.3
Manufacturing industry 276 366 200 965 75 401 27.3 85.3 92.9 8.6 8.9
Thereof:
Chemical industry 41 299 26 927 14 372 34.8 11.4 17.7 11.5 12.2
Chemical without 
pharmaceutical industry
22 623 17 694 4 929 21.8 7.5 6.1 10.1 8.1
Pharmaceutical industry 18 676 9 233 9 443 50.6 3.9 11.6 16.1 16.5
Machine building 41 337 33 595 7 741 18.7 14.3 9.5 7.1 6.6
Computer industry, electrical 
engineering, precision 
engineering
70 481 49 718 20 763 29.5 21.1 25.6 11.3 11.3
Vehicle construction 96 896 72 055 24 840 25.6 30.6 30.6 11.0 13.7
Automobile industry 85 656 69 359 16 298 19.0 29.5 20.1 11.4 13.8
Other vehicle construction 11 239 2 697 8 542 76.0 1.1 10.5 5.9 13.6
1   Percentage of R&D staff in relation to all employees of the respective sector.
Sources: SV-Wissenschaftsstatistik, calculations by DIW Berlin. DIW Berlin 2010
One in four researchers is employed by a foreign company. Foreign and domestic companies in Germany have similar sectoral preferences and R&D 
intensity.  German Companies Do Less Research Abroad
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From a German perspective, the USA is the most 
important origin/target country for R&D activities 
and knowledge exchange via multinational corpora-
tions, followed by Germany’s neighboring countries 
Switzerland, France, the Netherlands and Austria. 
So Germany’s main competitors in the field of best 
research conditions for companies are still the USA 
and a couple of Western European neighbors. But it 
is expected that fast growing countries like China 
and India will one day become important locations 
for foreign R&D activities of German companies as 
well. These countries are currently expanding their 
research infrastructure and are significantly increas-
ing their number of university graduates.
Germany’s international R&D 
balance is positive
In 2007, foreign companies invested about EUR 
4 billion more in R&D in Germany than German 
companies abroad. This makes the German research 
balance positive, after being in equilibrium until 
2001. For German multinational corporations, a gap 
has been opening up since 2001: While domestic 
R&D expenditures are increasing, R&D expendi-
tures abroad are on the decline.
This development is caused by companies of the 
automotive industry as well as computer industry, 
electrical engineering and precision engineering. In 
both sectors, Germany’s international R&D balance 
sheet was balanced at the beginning of the decade 
and has become positive because German compa-
nies have reduced their R&D activities abroad. At 
the same time, German automobile manufacturers 
have considerably expanded their domestic R&D ac-
tivities. This shows a high attractiveness of Germany 
as an R&D location in this sector. Also in the com-
puter industry, electrical engineering and precision 
engineering German companies are withdrawing 
from R&D abroad. However, their domestic R&D 
expenditures rose only slightly in the past years, as 
is the case for foreign companies in Germany.
In the chemical industry, Germany’s international 
R&D balance sheet is less positive. While it is bal-
anced in the research-intensive pharmaceutical 
industry, domestic R&D expenditures by German 
companies have halved between 2005 and 2007. 
Since total domestic R&D expenditures in the phar-
maceutical industry have been stagnating since 2005 
as well, this points towards a loss of importance 
of Germany as a location for pharmaceutical re-
search.
In the USA, the international R&D balance sheet 
has been positive for quite a while (Figure 3). This 
is nearly completely due to developments in the 
pharmaceutical industry. In the other two research-
intensive sectors with a high level of internationali-
zation, automotive engineering and computer and 
electronics industry, the international R&D balance 
sheet is negative (Figure 4).
In US pharmaceutical companies, R&D expen-
ditures increased more domestically than abroad 
in the past years. R&D expenditures by foreign 
companies in the USA amounted to nearly USD 
15 billion in 2007, which was twice the sum of US 
R&D expenditures abroad. The international R&D 
balance sheet increased significantly after 2005 in 
favor of the USA. The situation is different in the 
American automotive industry, where a negative 
US international R&D balance is worsening. At 
the same time, domestic R&D expenditures of US 
parent companies are stagnating. This points to-
wards disadvantages of this research location in the 
automobile industry. 
Foreign companies invest more in R&D in the 
USA—and since 2003 also in Germany—than 
domestic companies abroad. Both research loca-
tions are profiting from R&D internationalization 
in multinational corporations. The USA’s positive 
international R&D balance is mainly determined 
by the pharmaceutical industry; in Germany, the 
Table 3
Home and Target Country for R&D of Multinational 
Corporations
In percent
R&D staff of foreign companies  
in Germany in 2007
Patent applications of German 









Japan  3.3 2.3
South-East Asia 0.3 2.4
NAFTA (USA, Canada, Mexico) 38.9 30.7
Other countries 1.7 2.2
Total 100 100
1   At the European Patent Office including PCT. 
Sources: SV-Wissenschaftsstatistik, European Patent Office, 
PATSTAT version 1/2008, calculations by DIW Berlin. DIW Berlin 2010
Knowledge exchange mainly happens among affiliated companies in European neigh-
boring countries and with the USA.138
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decisive factor is the automobile industry. The most 
important contributions to the establishment and 
strengthening of these sectoral centers of gravity 
for R&D come from the respective domestic parent 
companies. In the American pharmaceutical indus-
try, foreign companies have also contributed a lot 
with their strongly increasing R&D expenditures.
R&D internationalization is not 
characterized by relocations
An analysis of the sectoral internationalization pat-
tern of R&D in Germany shows that relocation of 
domestic R&D capacities to other countries is no 
important reason for R&D internationalization. 
Relocations could be assumed if R&D expendi-
tures by German companies abroad increased more 
quickly abroad than in Germany. This could only 
be observed between 1999 and 2001. But in this 
period also domestic R&D expenditures by foreign 
companies increased significantly. In comparison, 
domestic R&D expenditures by German multina-
tional companies increased only slightly. The reason 
for this development could very well be the sale of 
researching affiliates to foreign owners. The sale 
of German Hoechst AG to the French corporation 
Rhône-Poulenc in 1999 alone probably accounts 
for most of this trend. About half of global R&D 
expenditures of Hoechst AG in 1998 were made in 
Germany—nearly EUR 2 billion.11
11 See Eckert, S.: Auf dem Weg zur Aktionsärsorientierung: Shareholder 
Value bei Hoechst. In: Streeck, W., Höpner, M. (Hrsg.): Alle Macht dem 
Markt? Fallstudien zur Abwicklung der Deutschland AG. Frankfurt/New 
York 2003.
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The USA’s international R&D balance is positive. 
Figure 4 
R&D Expenditures of American 
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R&D expenditures of the pharmaceutical industry focus 
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(First published as “Deutsche Unternehmen forschen 
weniger im Ausland”, in: Wochenbericht des DIW 
Berlin Nr. 20/2010.) 
Figure 5 
R&D Expenditures of Foreign 
companies in Selected Countries 
In percent 










1    Canada: 2004, Sweden: 2005, Finland, France and Japan: 2006.
Sources: OECD, national sources, calculations by DIW Berlin. 
    DIW Berlin 2010
In most countries the percentage of foreign companies in 
business R&D activities have hardly changed since 2001. 
However, the decline in R&D expenditures of 
German companies abroad between 2001 and 2007 
was hardly the result of many relocations. R&D 
expenditures of German companies abroad did go 
down by EUR 2.5 billion, but their domestic R&D 
expenditures rose by EUR 6.7 billion until 2007. 
Internationalization and re-nationalization of R&D 
in multinational corporations is mainly part of re-
structuring processes in the context of expanding 
or downsizing a company. It is takeovers and sales 
of researching companies that influence this de-
velopment, not mere relocation of R&D capacities 
between different countries. This is also proven by 
a 2005 study conducted with representatives of 250 
multinational corporations mainly from Western 
Europe and the USA. They were asked about their 
motivation for and the type of their new R&D loca-
tions. Only one in four of new or planned R&D sites 
abroad were described as “relocation” whilst the rest 
were characterized as “expansion” of R&D.12
In Germany, internal internationalization of R&D 
has come to a halt since the beginning of the new 
millennium after a strong increase at the end of 
the 1990s. Externally it has even decreased. Also 
in the USA, the UK, France and Sweden the proc-
ess of internal R&D internationalization has not 
significantly  improved  since  2001  (Figure  5). 
Externally this is at least also true for Sweden and 
Japan, whose percentage of R&D expenditures of 
domestic companies abroad in relation to domestic 
R&D expenditures has not increased since 2001.13 
Only multinational US corporations had a stronger 
increase of R&D expenditures abroad between 2001 
and 2007 than was the case in the USA.
Conclusion
Over the last years, Germany and the USA have 
profited from the internationalization of R&D ac-
tivities of multinational companies. After having 
a balanced international R&D balance sheet until 
2001, Germany now receives EUR 4 billion more 
of investments by foreign companies in Germany 
than German companies invest abroad.
Strategic restructuring is at the core of companies’ 
decision-making, not relocation of research sites. 
This is why cost reduction for R&D, e.g. through 
currently discussed tax incentives in addition to 
existing R&D project funding, will hardly result in 
backshoring of R&D capacities to Germany.
12 Thursby, J.G., Thursby, M.C., in the place cited
13 See  online  OECD  database,  globalization:  stats.oecd.org/index.
aspx?r=85052
The worldwide global and financial crisis has some-
what stopped internationalization if we take direct 
investment and cross-border company sales and 
mergers in 2008 as evidence.14 This will curb further 
internationalization of R&D.
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